Is it time for a new look at granulocyte transfusions?
- 8 November 2002
- journal article
- Published by Wiley in Transfusion
- Vol. 42 (11) , 1393-1395
- https://doi.org/10.1046/j.1537-2995.2002.00296.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donorsTransfusion, 2002
- Kinetics of G–CSF‐induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasoneTransfusion, 2002
- Administration of G–CSF plus dexamethasone producesgreater granulocyte concentrate yields while causing nomore donor toxicity than G–CSF aloneTransfusion, 2001
- Combined administration of G–CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosingTransfusion, 2000
- Effects of granulocyte–colony‐stimulating factor on potential normal granulocyte donorsTransfusion, 1999
- A comparative trial of granulocyte‐colony‐stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteersTransfusion, 1997
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Granulocyte transfusion therapy and amphotericin B: Adverse reactions?American Journal of Hematology, 1989
- Effects of storage of granulocytes on their fate in vivoTransfusion, 1983
- Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte TransfusionsNew England Journal of Medicine, 1981